Resource
CD62L Enrichment Achieves Robust Expansion and Memory Phenotype Post-Infusion in Patients with LBCL Treated with Rondecabtagene Autoleucel, an Autologous, Dual-Targeting CD19/CD20 CAR T-Cell Candidate
Publication Date: December 7, 2025
Source: ASH
DOI: DOI: 10.1182/blood-2025-501
Author(s): Akil Merchant, Ben Harris, Lora Zhao, Sahithi Cheemalamarri, Shobha Potluri, Tahir Latif, Umar Farooq, Sarah M. Larson
Resource Type: Presentation